Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20973267

Download in:

View as

Triples

General Info

PMID
20973267